Skip to main content

$5.19 0.12 (2.37%)

High

$5.29

Low

$5.12

Trades

1,945

Turnover

$3,576,754

Volume

686,116
30 June 2023 at 4:10pm
Register to track AVH and receive email alerts.
Subject
AVH Ann: AVITA Medical Corporate Presentation May 2022

AVH Ann: RECELL System to be Presented at SCALE Dermatology Meeting

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Final Director's Interest Notice - Louis Drapeau

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: AVITA to Announce First Quarter 2022 Financial Results

AVH Ann: AVH - Resignation of Louis Drapeau from Board of Directors

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: RECELL Data to be Presented at American Burn Assoc. Meeting

AVH Ann: RECELL Vitiligo Protocol Presentation at Vitiligo Symposium

AVH Ann: AVITA Medical Webinar Alert 11am (AEDT) 24 March 2022

AVH Ann: AVITA Medical Announces Modification of BARDA Contract

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Cowen Conference Presentation

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Change of Director's Interest Notice-Michael Perry

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: AVITA Medical signs agreement with Premier Inc

AVH Ann: Appendix 4G and Corporate Governance Statement

AVH Ann: Financial Results December 21 Quarter and Transition Period

AVH Ann: Appendix 4E and Preliminary Final Report (Form 10-K)

AVH Ann: AVITA Medical Corporate Presentation

AVH Ann: AVITA (AVH) Announces RECELL Receives Japan PMDA Approval

AVH Ann: AVITA Medical to Present at Cowen Health Care Conference

AVH Ann: AVITA - Approval of New RECELL System Improved Ease of Use

AVH Ann: AVITA (AVH) Announces July 1- Dec 31, 2021 Financial Results

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: AVITA Medical to Present at the BTIG MedTech Conference

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Substantial Holder Notice

AVH Ann: RECELL Data to be Presented at Annual Boswick Symposium

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: JP Morgan Healthcare Conference Presentation

AVH Ann: AVITA Medical Announces Preliminary Unaudited Results

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: AVITA Medical Completes Enrollment in Pivotal Trial

AVH Ann: AVITA Medical Establishes Proof of Concept for Gene Therapy

AVH Ann: Change of Director's Interest Notice-Suzanne Crowe

AVH Ann: Change of Director's Interest Notice-Michael Perry

AVH Ann: Change of Director's Interest Notice-Louis Panaccio

AVH Ann: Change of Director's Interest Notice-Louis Drapeau

AVH Ann: Change of Director's Interest Notice-Jeremy Curnock Cook

AVH Ann: Change of Director's Interest Notice-Jan Stern Reed

AVH Ann: Change of Director's Interest Notice-James Corbett

AVH Ann: Notification regarding unquoted securities - AVH

Register to track AVH and receive email alerts.